Pluvicto (lutetium LU 177 vipivotide tetraxetan) extension
Ended Awarded Last action
- Contract number
- 36C25525N0282
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $166,146
Award facts
- Contract value 100% obligated
- $166,145.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Millburn, NJ 07041, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$99,687 | |
| Original award | $265,833 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, received a $166,145.70 firm fixed price Blanket Purchase Agreement (BPA) call for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) on March 28, 2025. This extension contract, which completes July 31, 2025, was awarded by Veterans Integrated Service Network 15 without a small business set-aside designation and will be performed in Millburn, New Jersey. PLUVICTO is an advanced nuclear medicine product used for targeted radioligand therapy in cancer treatment, and this procurement fulfills the Department of Veterans Affairs' need to supply this specialized therapeutic agent to VA medical facilities.
This award represents a continuation of Advanced Accelerator Applications USA Inc.'s established relationship with the VA, leveraging an existing Blanket Purchase Agreement under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The company maintains significant contract vehicles across federal healthcare agencies, including substantial BPAs with VA Network Contracting Office 9 and the Defense Health Agency, positioning it as a primary supplier of critical nuclear medicine products to the federal government. The VISN 15 BPA call structure enables efficient and flexible ordering of PLUVICTO to support diagnostic and therapeutic medical procedures across VA healthcare systems.
Quick answers
Who was awarded contract 36C25525N0282?
36C25525N0282 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on March 28, 2025.
How much is contract 36C25525N0282 worth?
The government has obligated $166,146 on 36C25525N0282.
Is contract 36C25525N0282 an order under another contract?
Yes. 36C25525N0282 is a BPA call under 36F79719D0169-36C25524A0025, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25525N0282 competed?
The extent of competition for 36C25525N0282 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award